NK-ocking out cancer

How newly public NantKwest fits in Soon-Shiong's empire

Patrick Soon-Shiong is building what he hopes will be a suite of companies under the NantWorks LLC umbrella that together will help revolutionize cancer treatment. The latest is cancer immunotherapy company NantKwest Inc. (NASDAQ:NK), which went public last week a little over half a year after Soon-Shiong initially invested.

NantKwest is developing cancer immunotherapies based on what it calls activated natural killer (aNK) cells,

Read the full 642 word article

How to gain access

Continue reading with a
two-week free trial.